Drug information for PERPHENAZINE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CONCENTRATE; ORAL 16MG/5ML Discontinued   PERPHENAZINE Perphenazine PHARM ASSOC 40360
2001-05-25 Letter
TABLET; ORAL 16MG Prescription AB  PERPHENAZINE Perphenazine VINTAGE PHARMS 40226
2004-06-14 Letter

2004-06-14 Label

2003-07-30 Review
TABLET; ORAL 2MG Prescription AB  PERPHENAZINE Perphenazine VINTAGE PHARMS   "
TABLET; ORAL 4MG Prescription AB  PERPHENAZINE Perphenazine VINTAGE PHARMS   "
TABLET; ORAL 8MG Prescription AB  PERPHENAZINE Perphenazine VINTAGE PHARMS   "
TABLET; ORAL 8MG Discontinued   PERPHENAZINE Perphenazine IVAX PHARMS 89456
TABLET; ORAL 16MG Discontinued   PERPHENAZINE Perphenazine IVAX PHARMS 89457
TABLET; ORAL 2MG Prescription AB  PERPHENAZINE Perphenazine SANDOZ 89683
TABLET; ORAL 4MG Prescription AB  PERPHENAZINE Perphenazine SANDOZ 89684
TABLET; ORAL 8MG Prescription AB  PERPHENAZINE Perphenazine SANDOZ 89685
TABLET; ORAL 16MG Prescription AB (Reference Drug) PERPHENAZINE Perphenazine SANDOZ 89686
TABLET; ORAL 2MG Discontinued   PERPHENAZINE Perphenazine IVAX PHARMS 89707
TABLET; ORAL 4MG Discontinued   PERPHENAZINE Perphenazine IVAX PHARMS 89708

Drug Adverse Effects information for PERPHENAZINE

Role code Indications Reaction # Reports
SS AGITATION ILEUS PARALYTIC 1
SS DEMENTIA CHEST INJURY 1
SS DEMENTIA CONFUSIONAL STATE 1
SS DEMENTIA EXCORIATION 1
SS DEMENTIA FALL 1
SS DEMENTIA HALLUCINATION 1
SS DEMENTIA HEAD INJURY 1
SS DEPRESSION CHEST INJURY 1
SS DEPRESSION CONFUSIONAL STATE 1
SS DEPRESSION EXCORIATION 1
SS DEPRESSION FALL 1
SS DEPRESSION HALLUCINATION 1
SS DEPRESSION HEAD INJURY 1
SS EXTRAPYRAMIDAL DISORDER ILEUS PARALYTIC 1
SS PRODUCT USED FOR UNKNOWN INDICATION COMPLETED SUICIDE 3
SS PRODUCT USED FOR UNKNOWN INDICATION ILEUS PARALYTIC 4
SS PRODUCT USED FOR UNKNOWN INDICATION PLEUROTHOTONUS 24
C ANXIETY DEPRESSED LEVEL OF CONSCIOUSNESS 1
C ANXIETY PERSONALITY CHANGE 1
C ASTHMA ANAEMIA 2
C ASTHMA C-REACTIVE PROTEIN INCREASED 2
C ASTHMA CANDIDIASIS 2
C ASTHMA DRUG HYPERSENSITIVITY 2
C ASTHMA EOSINOPHIL COUNT INCREASED 2
C ASTHMA ERYTHEMA 2
C ASTHMA ERYTHEMA MIGRANS 2
C ASTHMA HAEMATOCHEZIA 2
C ASTHMA HAEMATOCRIT DECREASED 2
C ASTHMA HISTONE ANTIBODY POSITIVE 2
C ASTHMA LOGORRHOEA 2
C ASTHMA MUSCLE MASS 2
C ASTHMA MUSCLE TWITCHING 2
C ASTHMA OEDEMA PERIPHERAL 2
C ASTHMA PRURITUS 2
C ASTHMA RED BLOOD CELL SEDIMENTATION RATE INCREASED 2
C ASTHMA SKIN REACTION 2
C ASTHMA TRANSFERRIN INCREASED 2
C BIPOLAR DISORDER ADVERSE EVENT 1
C BIPOLAR DISORDER BLOOD CHOLESTEROL INCREASED 1
C BIPOLAR DISORDER DIABETIC COMA 2
C BIPOLAR DISORDER GLAUCOMA 1
C BIPOLAR DISORDER HYPERGLYCAEMIA 1
C BIPOLAR DISORDER LIVER FUNCTION TEST ABNORMAL 2
C BIPOLAR DISORDER TYPE 2 DIABETES MELLITUS 2
C BIPOLAR DISORDER WEIGHT INCREASED 1
C BIPOLAR I DISORDER DIABETIC COMA 2
C BIPOLAR I DISORDER LIVER FUNCTION TEST ABNORMAL 2
C BIPOLAR I DISORDER TYPE 2 DIABETES MELLITUS 2
C CONVULSION PROPHYLAXIS EOSINOPHIL COUNT INCREASED 3
C CONVULSION PROPHYLAXIS GRAND MAL CONVULSION 3
C CONVULSION PROPHYLAXIS LYMPHOCYTE COUNT DECREASED 3
C CONVULSION PROPHYLAXIS MONOCYTE COUNT INCREASED 3
C CONVULSION PROPHYLAXIS SALIVARY HYPERSECRETION 3
C ERECTILE DYSFUNCTION ERECTILE DYSFUNCTION 1
C HYPOTHYROIDISM ANAEMIA 1
C HYPOTHYROIDISM C-REACTIVE PROTEIN INCREASED 1
C HYPOTHYROIDISM CANDIDIASIS 1
C HYPOTHYROIDISM DRUG HYPERSENSITIVITY 1
C HYPOTHYROIDISM EOSINOPHIL COUNT INCREASED 1
C HYPOTHYROIDISM ERYTHEMA 1
C HYPOTHYROIDISM ERYTHEMA MIGRANS 1
C HYPOTHYROIDISM HAEMATOCHEZIA 1
C HYPOTHYROIDISM HAEMATOCRIT DECREASED 1
C HYPOTHYROIDISM HISTONE ANTIBODY POSITIVE 1
C HYPOTHYROIDISM LOGORRHOEA 1
C HYPOTHYROIDISM MUSCLE MASS 1
C HYPOTHYROIDISM MUSCLE TWITCHING 1
C HYPOTHYROIDISM OEDEMA PERIPHERAL 1
C HYPOTHYROIDISM PRURITUS 1
C HYPOTHYROIDISM RED BLOOD CELL SEDIMENTATION RATE INCREASED 1
C HYPOTHYROIDISM SKIN REACTION 1
C HYPOTHYROIDISM TRANSFERRIN INCREASED 1
C LOCALISED INFECTION BLOOD CALCIUM DECREASED 2
C LOCALISED INFECTION BLOOD CREATININE INCREASED 2
C LOCALISED INFECTION BLOOD UREA INCREASED 2
C LOCALISED INFECTION EOSINOPHIL COUNT INCREASED 2
C LOCALISED INFECTION FUNGAL INFECTION 2
C LOCALISED INFECTION HEADACHE 2
C LOCALISED INFECTION NEUTROPHIL COUNT INCREASED 2
C LOCALISED INFECTION PROTEIN TOTAL DECREASED 2
C LOCALISED INFECTION PROTEIN URINE PRESENT 2
C LOCALISED INFECTION PYREXIA 2
C LOCALISED INFECTION RENAL FAILURE ACUTE 2
C LOCALISED INFECTION RESPIRATORY TRACT INFECTION 2
C LOCALISED INFECTION TUBULOINTERSTITIAL NEPHRITIS 2
C LOCALISED INFECTION URINARY TRACT INFECTION 2
C LOCALISED INFECTION VIRAL INFECTION 2
C LOCALISED INFECTION WHITE BLOOD CELL COUNT INCREASED 2
C OESOPHAGITIS ANAEMIA 1
C OESOPHAGITIS C-REACTIVE PROTEIN INCREASED 1
C OESOPHAGITIS CANDIDIASIS 1
C OESOPHAGITIS DRUG HYPERSENSITIVITY 1
C OESOPHAGITIS EOSINOPHIL COUNT INCREASED 1
C OESOPHAGITIS ERYTHEMA 1
C OESOPHAGITIS ERYTHEMA MIGRANS 1
C OESOPHAGITIS HAEMATOCHEZIA 1
C OESOPHAGITIS HAEMATOCRIT DECREASED 1
C OESOPHAGITIS HISTONE ANTIBODY POSITIVE 1
C OESOPHAGITIS LOGORRHOEA 1
C OESOPHAGITIS MUSCLE MASS 1
C OESOPHAGITIS MUSCLE TWITCHING 1
C OESOPHAGITIS OEDEMA PERIPHERAL 1
C OESOPHAGITIS PRURITUS 1
C OESOPHAGITIS RED BLOOD CELL SEDIMENTATION RATE INCREASED 1
C OESOPHAGITIS SKIN REACTION 1
C OESOPHAGITIS TRANSFERRIN INCREASED 1
C PSYCHOTIC DISORDER ARTHRALGIA 1
C PSYCHOTIC DISORDER INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
C PSYCHOTIC DISORDER SOMNOLENCE 1
C PSYCHOTIC DISORDER UNDERDOSE 1
C SALIVARY HYPERSECRETION EOSINOPHIL COUNT INCREASED 3
C SALIVARY HYPERSECRETION GRAND MAL CONVULSION 3
C SALIVARY HYPERSECRETION LYMPHOCYTE COUNT DECREASED 3
C SALIVARY HYPERSECRETION MONOCYTE COUNT INCREASED 3
C SALIVARY HYPERSECRETION SALIVARY HYPERSECRETION 3
C SCHIZOAFFECTIVE DISORDER ARTHRALGIA 1
C SCHIZOAFFECTIVE DISORDER BALLISMUS 1
C SCHIZOAFFECTIVE DISORDER CHOREOATHETOSIS 1
C SCHIZOAFFECTIVE DISORDER DYSARTHRIA 1
C SCHIZOAFFECTIVE DISORDER DYSKINESIA 1
C SCHIZOAFFECTIVE DISORDER DYSTONIA 1
C SCHIZOAFFECTIVE DISORDER GAIT DISTURBANCE 1
C SCHIZOAFFECTIVE DISORDER GRIMACING 1
C SCHIZOAFFECTIVE DISORDER INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
C SCHIZOAFFECTIVE DISORDER MENTAL DISORDER 1
C SCHIZOAFFECTIVE DISORDER MUSCULOSKELETAL DISCOMFORT 1
C SCHIZOAFFECTIVE DISORDER PROTRUSION TONGUE 1
C SCHIZOAFFECTIVE DISORDER SOMNOLENCE 1
C SCHIZOAFFECTIVE DISORDER TARDIVE DYSKINESIA 1
C SCHIZOAFFECTIVE DISORDER TONGUE DISORDER 1
C SCHIZOAFFECTIVE DISORDER UNDERDOSE 1
C SCHIZOPHRENIA ABDOMINAL DISTENSION 1
C SCHIZOPHRENIA AGGRESSION 9
C SCHIZOPHRENIA AGITATION 10
C SCHIZOPHRENIA ANAEMIA 1
C SCHIZOPHRENIA ANGER 9
C SCHIZOPHRENIA ATELECTASIS 9
C SCHIZOPHRENIA BALLISMUS 1
C SCHIZOPHRENIA C-REACTIVE PROTEIN INCREASED 10
C SCHIZOPHRENIA CANDIDIASIS 1
C SCHIZOPHRENIA CARDIAC MURMUR 1
C SCHIZOPHRENIA CHOREOATHETOSIS 1
C SCHIZOPHRENIA DEATH 1
C SCHIZOPHRENIA DIABETES MELLITUS 1
C SCHIZOPHRENIA DRUG HYPERSENSITIVITY 1
C SCHIZOPHRENIA DYSARTHRIA 1
C SCHIZOPHRENIA DYSKINESIA 1
C SCHIZOPHRENIA DYSTONIA 1
C SCHIZOPHRENIA EOSINOPHIL COUNT INCREASED 19
C SCHIZOPHRENIA ERYTHEMA 1
C SCHIZOPHRENIA ERYTHEMA MIGRANS 1
C SCHIZOPHRENIA GAIT DISTURBANCE 1
C SCHIZOPHRENIA GRAND MAL CONVULSION 18
C SCHIZOPHRENIA GRIMACING 1
C SCHIZOPHRENIA HAEMATOCHEZIA 1
C SCHIZOPHRENIA HAEMATOCRIT DECREASED 1
C SCHIZOPHRENIA HEPATIC FUNCTION ABNORMAL 9
C SCHIZOPHRENIA HISTONE ANTIBODY POSITIVE 1
C SCHIZOPHRENIA ILEUS PARALYTIC 1
C SCHIZOPHRENIA IRRITABILITY 9
C SCHIZOPHRENIA LOGORRHOEA 1
C SCHIZOPHRENIA LYMPHOCYTE COUNT DECREASED 18
C SCHIZOPHRENIA MENTAL DISORDER 1
C SCHIZOPHRENIA MONOCYTE COUNT INCREASED 18
C SCHIZOPHRENIA MUSCLE MASS 1
C SCHIZOPHRENIA MUSCLE TWITCHING 1
C SCHIZOPHRENIA MUSCULOSKELETAL DISCOMFORT 1
C SCHIZOPHRENIA NEUTROPHIL COUNT DECREASED 9
C SCHIZOPHRENIA OEDEMA PERIPHERAL 1
C SCHIZOPHRENIA PLATELET COUNT DECREASED 9
C SCHIZOPHRENIA PLEURAL EFFUSION 9
C SCHIZOPHRENIA PLEURISY 9
C SCHIZOPHRENIA PROTEINURIA 1
C SCHIZOPHRENIA PROTRUSION TONGUE 1
C SCHIZOPHRENIA PRURITUS 1
C SCHIZOPHRENIA PYREXIA 9
C SCHIZOPHRENIA RED BLOOD CELL SEDIMENTATION RATE INCREASED 1
C SCHIZOPHRENIA SALIVARY HYPERSECRETION 18
C SCHIZOPHRENIA SKIN REACTION 1
C SCHIZOPHRENIA TARDIVE DYSKINESIA 1
C SCHIZOPHRENIA THERAPEUTIC RESPONSE DECREASED 1
C SCHIZOPHRENIA THIRST 9
C SCHIZOPHRENIA TONGUE DISORDER 1
C SCHIZOPHRENIA TRANSFERRIN INCREASED 1
C SCHIZOPHRENIA WHITE BLOOD CELL COUNT DECREASED 10
C SCHIZOPHRENIA, PARANOID TYPE EOSINOPHIL COUNT INCREASED 3
C SCHIZOPHRENIA, PARANOID TYPE GRAND MAL CONVULSION 3
C SCHIZOPHRENIA, PARANOID TYPE LYMPHOCYTE COUNT DECREASED 3
C SCHIZOPHRENIA, PARANOID TYPE MONOCYTE COUNT INCREASED 3
C SCHIZOPHRENIA, PARANOID TYPE SALIVARY HYPERSECRETION 3
C SLEEP DISORDER THERAPY DIABETIC COMA 2
C SLEEP DISORDER THERAPY LIVER FUNCTION TEST ABNORMAL 2
C SLEEP DISORDER THERAPY TYPE 2 DIABETES MELLITUS 2
C TYPE 2 DIABETES MELLITUS ANAEMIA 2
C TYPE 2 DIABETES MELLITUS C-REACTIVE PROTEIN INCREASED 2
C TYPE 2 DIABETES MELLITUS CANDIDIASIS 2
C TYPE 2 DIABETES MELLITUS DRUG HYPERSENSITIVITY 2
C TYPE 2 DIABETES MELLITUS EOSINOPHIL COUNT INCREASED 2
C TYPE 2 DIABETES MELLITUS ERYTHEMA 2
C TYPE 2 DIABETES MELLITUS ERYTHEMA MIGRANS 2
C TYPE 2 DIABETES MELLITUS HAEMATOCHEZIA 2
C TYPE 2 DIABETES MELLITUS HAEMATOCRIT DECREASED 2
C TYPE 2 DIABETES MELLITUS HISTONE ANTIBODY POSITIVE 2
C TYPE 2 DIABETES MELLITUS LOGORRHOEA 2
C TYPE 2 DIABETES MELLITUS MUSCLE MASS 2
C TYPE 2 DIABETES MELLITUS MUSCLE TWITCHING 2
C TYPE 2 DIABETES MELLITUS OEDEMA PERIPHERAL 2
C TYPE 2 DIABETES MELLITUS PRURITUS 2
C TYPE 2 DIABETES MELLITUS RED BLOOD CELL SEDIMENTATION RATE INCREASED 2
C TYPE 2 DIABETES MELLITUS SKIN REACTION 2
C TYPE 2 DIABETES MELLITUS TRANSFERRIN INCREASED 2
Ads by Google